CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 290 enrolled
Drug / intervention
Mistletoe extract (Iscador Qu) +1 moredrug
Likely dose
Mistletoe extract (Iscador Qu) 1mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02948309
NCT02948309Phase 3Completed
CompareCT.gov

Mistletoe Therapy in Primary & Recurrent Inoperable Pancreatic Cancer. A Phase III Prospective Randomized Double Blinded Multicenter Parallel Group Placebo Controlled Clinical Trial on Overall Survival and Quality of Life

Karolinska University Hospital·interventional·Posted Oct 28, 2016·Updated Jan 13, 2023

In Brief

A Phase 3 clinical trial evaluating Mistletoe extract (Iscador Qu) and Placebo for Pancreatic Cancer. Completed, enrolled 290 participants across 1 site.

Detailed Summary

In this study a mistletoe preparation (Iscador Qu) is added to standard therapy in inoperable pancreatic cancer in order to evaluate effect on overall survival and health-related quality of life. Half of participants will take subcutaneous injections with mistletoe in addition to standard therapy (palliative chemotherapy or best supportive care); the other half will receive a placebo and standard therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Cancer
CountriesSweden
CollaboratorsUniversity of Witten/Herdecke, Karolinska Institutet, Regional Cancer Centre Stockholm Gotland, Stiftelsen Konung Gustaf V:s Jubileumsfond för cancerforskning, Signe & Ane Gyllenbergs Stiftelse, Ekhagastiftelsen, Dagmar Ferbs Minnesfond, Cancerforskningsfonden i Norrland, Immunpathologisches Labor, University Tübingen, The Sjöberg Foundation

Timeline

Phase 3CompletedFinished
2017201820192020202120222023202420252026
First PostedOct 28, 2016
Enrollment StartJun 1, 2016
Primary CompletionSep 1, 2022
TodayJul 2, 2026
Enrollment to primary: 6.3 yearsPosted 9.7 years ago

Interventions

Mistletoe extract (Iscador Qu)drug

1ml subcutaneous injection 3 times/week, dose escalation 0,01mg - 20mg

Placebodrug

1ml subcutaneous injection 3 times/week